166
Views
2
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Daughters of polycystic ovary syndrome pregnancies and androgen levels in puberty: a Meta-analysis

, ORCID Icon, ORCID Icon, , , ORCID Icon, & show all
Pages 822-830 | Received 17 Mar 2022, Accepted 31 Aug 2022, Published online: 14 Sep 2022

References

  • Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
  • Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2(1):16057.
  • Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod. 2009;24(7):1548–1555.
  • Risal S, Pei Y, Lu H, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894–1904.
  • Legro RS, Driscoll D, Strauss JF, 3rd, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 1998;95(25):14956–14960.
  • Vink JM, Sadrzadeh S, Lambalk CB, et al. Heritability of poly cystic ovary syndrome in a dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100–2104.
  • Kahsar-Miller M, Azziz R. The development of the polycystic ovary syndrome: family history as a risk factor. Trends Endocrinol Metab. 1998;9(2):55–58.
  • Bruni V, Capozzi A, Lello S. The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art. Reprod Sci. 2022;29:668–679.
  • Abbott DH, Kraynak M, Dumesic DA, et al. In utero androgen excess: a developmental commonality preceding polycystic ovary syndrome? Front Horm Res. 2019;53:1–17.
  • Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1(8489):1077–1081.
  • Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;341(8850):938–941.
  • Stener-Victorin E, Padmanabhan V, Walters KA, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4):1–39.
  • Sir-Petermann T, Maliqueo M, Angel B, et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002;17(10):2573–2579.
  • Maliqueo M, Lara HE, Sánchez F, et al. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):151–155.
  • Palomba S, Marotta R, Cello AD, et al. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case- control study. Clin Endocrinol (Oxf). 2012;77(6):898–904.
  • Duan C, Pei T, Li Y, et al. Androgen levels in the fetal cord blood of children born to women with polycystic ovary syndrome: a Meta-analysis. Reprod Biol Endocrinol. 2020;18(1):81.
  • Barrett ES, Hoeger KM, Sathyanarayana S, et al. Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. J Dev Orig Health Dis. 2018;9(3):307–314.
  • Perlman S, Toledano Y, Kivilevitch Z, et al. Foetal sonographic anogenital distance Is longer in polycystic ovary syndrome mothers. JCM. 2020;9(9):2863.
  • Homburg R, Gudi A, Shah A, et al. A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study. Reprod Biol Endocrinol. 2017;15(1):61. 8 8
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studiesin meta-analyses, 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • Sir-Petermann T, Ladrón de Guevara A, Codner E, et al. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome. Reprod Sci. 2012;19(4):383–390.
  • Sir-Petermann T, Codner E, Pérez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1923–1930.
  • Olszanecka-Glinianowicz M, Zachurzok A, Drosdzol-Cop A, et al. Circulating Anti-Müllerian hormone levels in daughters of women with and without polycystic ovary syndrome. Horm Res Paediatr. 2016;85(6):372–378.
  • Crisosto N, Ladrón de Guevara A, Echiburú B, et al. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome. Fertil Steril. 2019;111(2):381–388.
  • Sir-Petermann T, Maliqueo M, Codner E, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(12):4637–4642.
  • Maliqueo M, Galgani JE, Pérez-Bravo F, et al. Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):56–61.
  • Battaglia C, Regnani G, Mancini F, et al. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum Reprod. 2002;17(3):771–776.
  • Echiburú B, Pérez-Bravo F, Maliqueo M, et al. CAG repeat polymorphism of androgen receptor gene and X-chromosome inactivation in daughters of women with polycystic ovary syndrome (PCOS): relationship with endocrine and metabolic parameters. Gynecol Endocrinol. 2012;28(7):516–520.
  • Sir-Petermann T, Codner E, Maliqueo M, et al. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(8):3105–3109.
  • Hiam D, Moreno-Asso A, Teede HJ, et al. The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies. JCM. 2019;8(10):1606.
  • Daniels TL, Berga SL. Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation. J Clin Endocrinol Metab. 1997;82(12):4179–4183.
  • Blank SK, McCartney CR, Chhabra S, et al. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls–implications for regulation of pubertal maturation. J Clin Endocrinol Metab. 2009;94(7):2360–2366.
  • Chhabra S, McCartney CR, Yoo RY, et al. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J Clin Endocrinol Metab. 2005;90(5):2810–2815.
  • Pielecka J, Quaynor SD, Moenter SM. Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback. Endocrinology. 2006;147(3):1474–91479.
  • Moore AM, Prescott M, Campbell RE. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology. 2013;154(2):796–806.
  • Robinson JE, Forsdike RA, Taylor JA. In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone. Endocrinology. 1999;140(12):5797–5805.
  • Abbott DH, Vepraskas SH, Horton TH, et al. Accelerated episodic luteinizing hormone release accompanies blunted progesterone regulation in PCOS-like female rhesus monkeys (Macaca Mulatta) exposed to testosterone during early-to-Mid gestation. Neuroendocrinology. 2018;107(2):133–146.
  • Huang X, Harlan RE. Absence of androgen receptors in LHRH immunoreactive neurons. Brain Res. 1993;624(1-2):309–311.
  • Moore AM, Prescott M, Marshall CJ, et al. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome. Proc Natl Acad Sci U S A. 2015;112(2):596–601.
  • Tang R, Ding X, Zhu J. Kisspeptin and polycystic ovary syndrome. Front Endocrinol (Lausanne). 2019;10:298.
  • Tata B, Mimouni NEH, Barbotin AL, et al. Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834–846.
  • Li J, Cui L, Jiang X, et al. Transmission of polycystic ovary syndrome susceptibility single-nucleotide polymorphisms and their association with phenotype changes in offspring. Hum Reprod. 2020;35(7):1711–1718.
  • Dulka EA, Burger LL, Moenter SM. Ovarian androgens maintain high GnRH neuron firing rate in adult Prenatally-Androgenized female mice. Endocrinology. 2020;161(1):bqz038.
  • Dulka EA, Moenter SM. Prepubertal development of Gonadotropin-Releasing hormone neuron activity Is altered by sex, age, and prenatal androgen exposure. Endocrinology. 2017;158(11):3943–3953.
  • Koivuaho E, Laru J, Ojaniemi M, et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes (Lond). 2019;43(7):1370–1379.
  • Patel R, Shah G. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats. Reproduction. 2018;155(2):141–151.
  • Fernández M, Bourguignon N, Lux-Lantos V, et al. Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect. 2010;118(9):1217–1222.
  • Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord. 2010;8(5):375–394.
  • Blank SK, McCartney CR, Helm KD, et al. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med. 2007;25(5):352–359.
  • Ghizzoni L, Cappa M, Chrousos G, et al. Pediatric adrenal diseases. Endocr Dev. Basel, Karger. 2011;(20):20–27.
  • Maliqueo M, Sir-Petermann T, Pérez V, et al. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(9):3282–3288.
  • Legro RS, Kunselman AR, Stetter CM, et al. Normal pubertal development in daughters of women With PCOS: a controlled study. J Clin Endocrinol Metab. 2017;102(1):122–131.
  • de Zegher F, Reinehr T, Malpique R, et al. Reduced prenatal weight gain and/or augmented postnatal weight gain precedes polycystic ovary syndrome in adolescent girls. Obesity (Silver Spring). 2017;25(9):1486–1489.
  • de Zegher F, López-Bermejo A, Ibáñez L. Central obesity, faster maturation, and ‘PCOS’ in girls. Trends Endocrinol Metab. 2018;29(12):815–818.
  • Eisner JR, Dumesic DA, Kemnitz JW, et al. Abbott DH increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes Res. 2003;11(2):279–286.
  • Bruns CM, Baum ST, Colman RJ, et al. Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome. Int J Obes. 2007;31(10):1579–1585.
  • Toscano V, Balducci R, Bianchi P, et al. Sciarra F steroidal and non-steroidal factors in plasma sex hormone-binding globulin regulation. J Steroid Biochem Mol Biol. 1992;43(5):431–437.
  • Xita N, Tsatsoulis A, Chatzikyriakidou A, et al. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG levels. J Clin Endocrinol Metab. 2003;88(12):5976–5980.
  • Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril. 1992;58(4):655–666.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.